ClinicalTrials.govpublic full text
Safety & Activity of Controllable PRAME-TCR Therapy in Previously Treated AML/MDS or Metastatic Uveal Melanoma
acute myeloid leukemia, myelodysplastic syndrome, uveal melanoma, bpx-701, ap1903, rimiducid, aml, mds, relapsed aml, prame, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 844459
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.